等待开盘 07-06 09:30:00 美东时间
+0.370
+2.35%
--ASSFN program to feature thalamic neuromodulation, NAUTILUS data in idiopathic generalized epilepsy, and emerging applications for broader epilepsy populations----NeuroPace to engage neurosurgeon community through
05-29 20:13
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从11美元升至12美元;Ladenburg Thalmann:维持Usio"买入"评级,目标价从5.75美元升至6.25美元
05-18 11:48
HC Wainwright & Co. analyst Yi Chen maintains NeuroPace (NASDAQ:NPCE) with a Buy and raises the price target from $19 to $20.
05-16 01:35
Neuropace shares are trading lower. The company reported Q1 financial results.
05-13 21:19
NeuroPace (NASDAQ:NPCE) released first-quarter financial results and hosted an ...
05-13 05:38
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Neuropace shares are trading higher after the company reported better-than-expe...
03-04 05:14
NeuroPace (NASDAQ:NPCE) sees FY2026 sales of $98.000 million-$100.000 million vs $98.943 million analyst estimate.
03-04 05:08
NeuroPace (NASDAQ:NPCE) reported its Q4 earnings results on Tuesday, March 3, 2...
03-04 05:08
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is expected to rep...
03-03 19:11